Como mayorista farmacutico global con amplia experiencia en exportacin, distribuimos medicamentos genricos de alta calidad a pacientes, hospitales, mdicos, clnicas y centros de salud en pases como Colombia, Per, Filipinas, Venezuela, Panam, Ecuador, Namibia, Sudfrica, Zimbabue, Barin, Chipre, Egipto, Irn, Irak, Israel, Jordania, Palestina, Catar, Arabia Saudita, Emiratos rabes Unidos, China, Canad, Brasil, Mxico, Rusia, Tailandia, Malasia, Singapur, Vietnam, Corea del Sur, Taiwn, Indonesia, Estados Unidos y ms
February 2025 Hims & Hers oral semaglutide controversy: Strive manufactured the oral compounded semaglutide pill that Hims & Hers launched on February 5, 2025, using what Strive described as liposomal technology. Hims pulled the product two days after launch after coming under federal scrutiny
A total of 574 cases have been linked to GLP-1 receptor agonists, 10 of which resulted in fatalities, according to data from MHRAs Yellow Card Biobank
Unlike sarcopenia, which requires both loss of muscle quantity and reduced function, lean mass reduction is a body-composition outcome most often assessed using dual-energy X-ray absorptiometry (DXA) or bioimpedance analysis (BIA) [2, 20]
Risks and Side Effects of Allulose While allulose is generally recognized as safe, it can carry side effects, mainly symptoms of gastrointestinal (GI) upset such as bloating, gas, diarrhea, and stomachache, Poulson says
Jeremy Pettus, both living with Type 1 diabetes for over 30 years, compare Ozempic (semaglutide) and Mounjaro (tirzepatide) in this comprehensive head-to-head analysis